New search | Conferencedetail
Print view
 
 

International Cannabinoid Derived Pharmaceuticals Summit

evvnt Platform / evvnt
-
10.12.2018 - 12.12.2018  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 8:00 am - 6:00 pm
 
Conference themes
With 17+ hours of content, we will be tackling the key issues from the benchside to commercialization. By considering a range of therapeutic areas, the conference is designed exclusively for the Cannabinoid drug developer. Our speakers will discuss complex Cannabinoid pharmacology, formulations, clinical trials, patient education and commercial challenges.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Chris Bunka, Chairman of the Board and Chief Executive Officer, Lexaria Biosciences, Tamas Biro, Professor, Research Center for Molecular Medicine Departments of Immunology and Physiology, University of Debrecen, and others
 

Enquiries and Registration:

https://go.evvnt.com/267417-0?pid=4832
Ms. Kaltrina Kastrati
 
Categories
Pharmacology and Toxicology
Languages
English
Congress fees
Conference Only: GBP 1999.0, Conference + 2 Workshops: GBP 2897.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Helix - Forschung & Beratung WienÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrzte der WeltÄrztekammer für WienÖsterreichisches Rotes KreuznewTreeAnästhesie in Entwicklungsländern e. V.

Facebook

Give us your professional opinion

Start survey

Start survey